Home › Funds › Two Sigma Investments › EPRX
Two Sigma Investments position in EPRX
EUPRAXIA PHARMACEUTICALS INC · Health Care
Latest position (Q2 2026)221.08K sh
Reported value held$1.46M
Portfolio Weight0.00%
First reportedQ1 2026
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 10.80K | $78.19K | New |
| Q2 2026 | 221.08K | $1.46M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding EPRX
- Balyasny Asset Management 1.35M sh · $8.92M · Q2 2026
- Point72 Asset Management 730.28K sh · $4.83M · Q2 2026
- UBS Group AG 519.21K sh · $3.43M · Q2 2026
- Citadel Advisors 502.01K sh · $3.32M · Q2 2026
- Millennium Management 441.59K sh · $2.92M · Q2 2026
- Bank of America Corp 264.72K sh · $1.75M · Q2 2026
- Marshall Wace 158.13K sh · $1.05M · Q2 2026
- Goldman Sachs Group 58.06K sh · $383.76K · Q2 2026
- Geode Capital Management 36.21K sh · $239.35K · Q2 2026
- JPMorgan Chase & Co 14.19K sh · $93.49K · Q2 2026
- BlackRock Inc 6.09K sh · $40.24K · Q2 2026